Cytokinetics Heart Failure Drug Needs Another Phase III Study, US FDA Panel Says

 
• By Sarah Karlin-Smith
  
heart
Advisory panel says Cryokinetics needs to do more study for a narrower indication • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers